Clinical Trials
- Brain and Other Nervous System Cancers, Lung Cancer, Melanoma
A Phase II Trial of Pembrolizumab Plus Bevacizumab in Patients With Metastatic Melanoma or Non-small Cell Lung Cancer With Untreated Brain Metastases
- Ages18 years and older
- GenderBoth
- Date05/27/2016
An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 3 Study to Establish the Diagnostic Performance of 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy
- Ages18 years and older
- GenderBoth
- Date11/09/2020
- Lung Cancer
Determining Mechanisms of Sensitivity and Resistance to Anti-Cancer Therapy for Advanced Lung Cancer
- Date06/20/2016
- Brain, Spinal Cord & Nervous System
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN)
- GenderBoth
- Date01/23/2017